MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 162 filers reported holding MOMENTA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $47,778,000 | -21.4% | 910,419 | -50.2% | 0.01% | -30.8% |
| Q2 2020 | $60,767,000 | +28.4% | 1,826,493 | +4.9% | 0.01% | +8.3% |
| Q1 2020 | $47,341,000 | -19.9% | 1,740,512 | -41.9% | 0.01% | +100.0% |
| Q4 2019 | $59,120,000 | +241.3% | 2,996,542 | +124.2% | 0.01% | +50.0% |
| Q3 2019 | $17,322,000 | +7.9% | 1,336,621 | +3.7% | 0.00% | 0.0% |
| Q2 2019 | $16,050,000 | -8.9% | 1,289,229 | +6.4% | 0.00% | -20.0% |
| Q1 2019 | $17,613,000 | -24.7% | 1,212,194 | -42.8% | 0.01% | +25.0% |
| Q4 2018 | $23,384,000 | +6.4% | 2,118,228 | +153.4% | 0.00% | -33.3% |
| Q3 2018 | $21,987,000 | +34.6% | 836,029 | +4.6% | 0.01% | +20.0% |
| Q2 2018 | $16,337,000 | +23.7% | 798,883 | +9.8% | 0.01% | +25.0% |
| Q1 2018 | $13,207,000 | +28.2% | 727,675 | -1.5% | 0.00% | +33.3% |
| Q4 2017 | $10,302,000 | -24.8% | 738,507 | -0.2% | 0.00% | -40.0% |
| Q3 2017 | $13,695,000 | +30.7% | 740,322 | +19.4% | 0.01% | +25.0% |
| Q2 2017 | $10,479,000 | +48.4% | 620,156 | +17.3% | 0.00% | +33.3% |
| Q1 2017 | $7,059,000 | -2.0% | 528,877 | +10.5% | 0.00% | 0.0% |
| Q4 2016 | $7,202,000 | +32.8% | 478,588 | +3.1% | 0.00% | 0.0% |
| Q3 2016 | $5,424,000 | +14.9% | 464,031 | +6.2% | 0.00% | 0.0% |
| Q2 2016 | $4,721,000 | +20.1% | 437,137 | +2.7% | 0.00% | +50.0% |
| Q1 2016 | $3,931,000 | -33.5% | 425,511 | +6.7% | 0.00% | -33.3% |
| Q4 2015 | $5,914,000 | -8.9% | 398,618 | +0.8% | 0.00% | -25.0% |
| Q3 2015 | $6,492,000 | -25.8% | 395,638 | +3.2% | 0.00% | -20.0% |
| Q2 2015 | $8,744,000 | +100.2% | 383,394 | +33.4% | 0.01% | +150.0% |
| Q1 2015 | $4,367,000 | +31.4% | 287,363 | +4.1% | 0.00% | 0.0% |
| Q4 2014 | $3,324,000 | +4.8% | 276,161 | -1.3% | 0.00% | 0.0% |
| Q3 2014 | $3,173,000 | -12.4% | 279,859 | -6.7% | 0.00% | 0.0% |
| Q2 2014 | $3,623,000 | +32.5% | 300,014 | +27.8% | 0.00% | 0.0% |
| Q1 2014 | $2,734,000 | -31.3% | 234,685 | +4.2% | 0.00% | -33.3% |
| Q4 2013 | $3,982,000 | +26.7% | 225,269 | +3.2% | 0.00% | 0.0% |
| Q3 2013 | $3,142,000 | +10.6% | 218,358 | +15.8% | 0.00% | +50.0% |
| Q2 2013 | $2,840,000 | – | 188,595 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 450,000 | $7,605,000 | 3.18% |
| ARMISTICE CAPITAL, LLC | 820,000 | $13,858,000 | 1.77% |
| Marcus Capital, LLC | 104,000 | $1,758,000 | 1.50% |
| SECTOR GAMMA AS | 605,545 | $10,234,000 | 1.49% |
| Palo Alto Investors LP | 1,787,576 | $30,210,000 | 1.41% |
| SECTORAL ASSET MANAGEMENT INC | 299,400 | $5,060,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 433,060 | $7,318,000 | 0.53% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 1,232,929 | $20,837,000 | 0.51% |
| Orbimed Advisors | 2,109,068 | $35,643,000 | 0.37% |
| TFS CAPITAL LLC | 52,290 | $884,000 | 0.35% |